TherapeuticsMD Net Cash Flow from Operations from 2010 to 2024
| TXMD Stock | USD 1.92 0.04 2.13% |
Check TherapeuticsMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TherapeuticsMD main balance sheet or income statement drivers, such as Depreciation And Amortization of 630.2 K, Interest Expense of 14.8 M or Selling General Administrative of 26.4 M, as well as many exotic indicators such as Price To Sales Ratio of 17.14, Dividend Yield of 0.088 or PTB Ratio of 0.84. TherapeuticsMD financial statements analysis is a perfect complement when working with TherapeuticsMD Valuation or Volatility modules.
TherapeuticsMD | Net Cash Flow from Operations |
About TherapeuticsMD Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include TherapeuticsMD income statement, its balance sheet, and the statement of cash flows. TherapeuticsMD investors use historical funamental indicators, such as TherapeuticsMD's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although TherapeuticsMD investors may use each financial statement separately, they are all related. The changes in TherapeuticsMD's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on TherapeuticsMD's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on TherapeuticsMD Financial Statements. Understanding these patterns can help to make the right decision on long term investment in TherapeuticsMD. Please read more on our technical analysis and fundamental analysis pages.
TherapeuticsMD, Inc. operates as a womens healthcare company in the United States. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Therapeuticsmd operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 416 people.
Currently Active Assets on Macroaxis
When determining whether TherapeuticsMD is a strong investment it is important to analyze TherapeuticsMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TherapeuticsMD's future performance. For an informed investment choice regarding TherapeuticsMD Stock, refer to the following important reports:Check out the analysis of TherapeuticsMD Correlation against competitors. For information on how to trade TherapeuticsMD Stock refer to our How to Trade TherapeuticsMD Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for TherapeuticsMD Stock analysis
When running TherapeuticsMD's price analysis, check to measure TherapeuticsMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TherapeuticsMD is operating at the current time. Most of TherapeuticsMD's value examination focuses on studying past and present price action to predict the probability of TherapeuticsMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TherapeuticsMD's price. Additionally, you may evaluate how the addition of TherapeuticsMD to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is TherapeuticsMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TherapeuticsMD. If investors know TherapeuticsMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TherapeuticsMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Revenue Per Share 0.125 | Quarterly Revenue Growth (0.99) | Return On Assets (0.08) | Return On Equity (0.24) |
The market value of TherapeuticsMD is measured differently than its book value, which is the value of TherapeuticsMD that is recorded on the company's balance sheet. Investors also form their own opinion of TherapeuticsMD's value that differs from its market value or its book value, called intrinsic value, which is TherapeuticsMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TherapeuticsMD's market value can be influenced by many factors that don't directly affect TherapeuticsMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TherapeuticsMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if TherapeuticsMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TherapeuticsMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.